11:44 EDT Tenax Therapeutics (TENX) files $300M mixed securities shelf
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TENX:
- DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
- Cantor starts Tenax at Overweight into Phase 3 readout
- Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
- Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
- Tenax Therapeutics initiated with an Outperform at LifeSci Capital